Tag: <span>vorasidenib therapy</span>

Home / vorasidenib therapy
FDA approves new therapy for glioma patients for first time in decades
Post

FDA approves new therapy for glioma patients for first time in decades

August 7, 2024 by Dana-Farber Cancer Institute Glioma of the left parietal lobe. CT scan with contrast enhancement. Credit: Mikhail Kalinin/CC BY-SA 3.0Vorasidenib has been approved by the U.S. Food and Drug Administration (FDA) for patients with Grade 2 gliomas with IDH1 or IDH2 mutations. Based on evidence from the INDIGO clinical trial, a global...